Showing results (281-290 of 830) with videos related to

Sort By:
Pageof 83
Pharmacogenetics|August 13, 2002
Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populationsKun Tang, Soo-Mun Ngoi, Pai-Chung Gwee, et al.
Pharmacogenetics|August 13, 2002
A catalogue of polymorphisms related to xenobiotic metabolism and cancer susceptibilityFederica Gemignani, Stefano Landi, Franck Vivant, et al.
Pharmacogenetics|November 3, 2001
Glutathione S-transferase genotypes and stomach cancer in a population-based case-control study in Warsaw, PolandQ Lan, W H Chow, J Lissowska, et al.
Pharmacogenetics|November 3, 2001
Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 geneK L Mealey, S A Bentjen, J M Gay, et al.
Pharmacogenetics|August 16, 2001
Analysis of the CYP2D6 gene polymorphism and enzyme activity in African-Americans in southern CaliforniaY J Wan, R E Poland, G Han, et al.
Pharmacogenetics|August 16, 2001
CYP1A1 levels in lung tissue of tobacco smokers and polymorphisms of CYP1A1 and aromatic hydrocarbon receptorS Anttila, P Tuominen, A Hirvonen, et al.
Pharmacogenetics|August 16, 2001
Functional characterization of nucleotide polymorphisms in the coding region of N-acetyltransferase 1A J Fretland, M A Doll, M A Leff, et al.
Pharmacogenetics|August 16, 2001
Association of GSTT1 non-null and NAT1 slow/rapid genotypes with von Hippel-Lindau tumour suppressor gene transversions in sporadic renal cell carcinomaC Gallou, S Longuemaux, C Deloménie, et al.
Pharmacogenetics|July 27, 2001
Modulation of DNA and protein adducts in smokers by genetic polymorphisms in GSTM1,GSTT1, NAT1 and NAT2R W Godschalk, J W Dallinga, H Wikman, et al.
Pharmacogenetics|July 27, 2001
Characterization of the CYP2D6*29 allele commonly present in a black Tanzanian population causing reduced catalytic activityA Wennerholm, I Johansson, M Hidestrand, et al.
Pageof 83